Group 1 - The company will participate in the 2025 semi-annual performance briefing for the innovative drug industry on September 16, 2025, from 15:00 to 17:00 [2][3] - The briefing will be held in an online interactive format at the Shanghai Stock Exchange Roadshow Center [2][3] - Key personnel attending the briefing include Chairman and General Manager Zhengyu Yuan, CFO Li Zhile, Independent Director Zhang Huaiying, and Secretary of the Board Nie Anna [2] Group 2 - Investors can participate in the briefing by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date [2][3] - Investors are encouraged to submit questions from September 9 to September 15, 2025, through the designated online platform or via the company's email [3] - After the briefing, investors can view the main content and outcomes of the event on the Shanghai Stock Exchange Roadshow Center [3]
盟科药业: 上海盟科药业股份有限公司关于参加2025年半年度科创板创新药行业集体业绩说明会的公告